PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-78.03%
Negative revenue growth while 1475.HK stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
110.95%
Gross profit growth of 110.95% while 1475.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
No Data
No Data available this quarter, please select a different quarter.
-34.65%
Negative operating income growth while 1475.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-275.68%
Negative net income growth while 1475.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-281.68%
Negative EPS growth while 1475.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-281.68%
Negative diluted EPS growth while 1475.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.22%
Share change of 1.22% while 1475.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 1475.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.62%
OCF growth of 63.62% while 1475.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
62.89%
FCF growth of 62.89% while 1475.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-99.87%
Negative 10Y revenue/share CAGR while 1475.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.90%
Negative 5Y CAGR while 1475.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
No Data
No Data available this quarter, please select a different quarter.
-144.81%
Negative 10Y OCF/share CAGR while 1475.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-118.30%
Negative 5Y OCF/share CAGR while 1475.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
No Data
No Data available this quarter, please select a different quarter.
-465.09%
Negative 10Y net income/share CAGR while 1475.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-191.28%
Negative 5Y net income/share CAGR while 1475.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Cut dividends over 10 years while 1475.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 1475.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.24%
We have a declining book value while 1475.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.63%
We cut SG&A while 1475.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.